Advertisements provide a way for people to get informed about new treatments

The argument

Direct-to-consumer advertising has been an effective way to inform people about potential treatments for health issues, and the argument for it begins with a limitation of the system that is supposed to make advertising unnecessary. As pharmaceuticals continue to evolve and new treatments are created for various health issues, even doctors themselves cannot always keep up. The volume of new products is large, the pace is continuous, and no clinician can hold the whole of it in view across every condition they encounter. Doctors are also human and not infallible. Treating the prescriber as a complete filter therefore assumes something that is not true of any individual practitioner, however well trained. If that filter is imperfect, the patient needs some independent route to the information. It is vital for patients to be equipped with knowledge of the treatments available to them so that they are able to self-advocate on behalf of their own health — which means knowing that an option exists in order to ask about it at all. A patient who has never heard of a treatment cannot raise it, and a treatment that is never raised in the consulting room is, for that patient, unavailable. The model already exists elsewhere and is widely accepted. With the advent of websites like WebMD, patients research their own health issues and arrive better informed about their condition and about how to navigate it with a healthcare provider. The information does not replace the clinician; it changes the quality of the conversation with them. DTC advertising is no different in this respect. Whatever its commercial motive, it reaches people who are not searching — people who do not yet know there is anything to look for — which makes it an invaluable way of getting that information to people everywhere.

Premises

Counter-arguments

It has been documented several times over that people searching for their physical symptoms is not a good idea and only leads patients to self-diagnose and potentially take medications based on their own diagnosis. This can have deadly effects, and can also create a sense of distrust in those in the medical profession to correctly diagnose and treat them. While doctors are not above error, it does not mean that they are less knowledgeable about the medical profession than someone who is not a doctor. DTC undermines the authority of doctors to do their jobs, while potentially putting patients’ lives at risk just for the sake of profit.

Rejecting the premises

[Rejecting P1] Advertising is not a neutral information channel. It is bought by the maker of one drug, so what it conveys is selected to sell that product rather than to survey the treatments available for a condition. [Rejecting P2] Doctors' fallibility is an argument for second opinions, better prescribing guidance and continuing education, not for marketing aimed at patients. A patient holding an advertisement is not thereby better placed to judge a diagnosis. [Rejecting P3] The comparison with symptom-research sites undercuts the premise as much as it supports it: the counter-argument notes that self-directed research of this kind is widely held to encourage self-diagnosis and pressure on prescribers, which is the very outcome the premise counts as a benefit.